Literature DB >> 27161643

Study of Two Separate Types of Macrolide-Resistant Mycoplasma pneumoniae Outbreaks.

Yingshuo Wang1, Qian Ye1, Dehua Yang1, Zhimin Ni2, Zhimin Chen3.   

Abstract

To study the complete natural process of a Mycoplasma pneumoniae outbreak in a semiclosed room such as a primary school room, we investigated two separate M. pneumoniae outbreaks involving 81 students in total in two primary schools in Hangzhou, China. M. pneumoniae isolates from pharyngeal swabs were detected by fluorescence quantitative real-time PCR (RT-PCR) and culture. The class in school M had 39 students, with 12 (30.8%) with positive M. pneumoniae detection results. The class from school J had 42 students, with 13 (31.0%) positive. The strains from two classes were confirmed to represent two clones (3/4/5/7/2 and 5/4/5/7/2) and to be macrolide resistant (A2063G) according to P1 and multilocus variable-number tandem-repeat analysis (MLVA) genotyping, determination of MIC of antibiotics, and sequencing. Students with M. pneumoniae isolates detected were divided into three groups: those carrying the isolates, those with upper respiratory tract infection (URI), and those with pneumonia. Longitudinal sampling performed using pharyngeal swabs showed that the persistence of M. pneumoniae was longest in the group of students with pneumonia. M. pneumoniae causes pneumonia outbreaks in schools, and the incidence of pneumonia has a higher rate than that of URI. The persistence of M. pneumoniae, with a median duration of 79.50 days in the group of students with pneumonia, differs from that of the infection state.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27161643      PMCID: PMC4914620          DOI: 10.1128/AAC.00198-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  Molecular typing of Mycoplasma pneumoniae strains by PCR-based methods and pulsed-field gel electrophoresis. Application to French and Danish isolates.

Authors:  A Cousin-Allery; A Charron; B de Barbeyrac; G Fremy; J Skov Jensen; H Renaudin; C Bebear
Journal:  Epidemiol Infect       Date:  2000-02       Impact factor: 2.451

2.  ICD-9-CM. International Classification of Diseases, 9th revision, Clinical Modification. 3d edition, volumes 1, 2 and 3. Official authorized addendum effective October 1, 1990--HCFA.

Authors: 
Journal:  J Am Med Rec Assoc       Date:  1990-08

3.  Development of multiple-locus variable-number tandem-repeat analysis for molecular typing of Mycoplasma pneumoniae.

Authors:  S Dégrange; C Cazanave; A Charron; H Renaudin; C Bébéar; C M Bébéar
Journal:  J Clin Microbiol       Date:  2009-02-09       Impact factor: 5.948

4.  Evaluation of three real-time PCR assays for detection of Mycoplasma pneumoniae in an outbreak investigation.

Authors:  Jonas M Winchell; Kathleen A Thurman; Stephanie L Mitchell; W Lanier Thacker; Barry S Fields
Journal:  J Clin Microbiol       Date:  2008-07-09       Impact factor: 5.948

5.  High rate of nasopharyngeal carriage of potential pathogens among children in Greenland: results of a clinical survey of middle-ear disease.

Authors:  P Homøe; J Prag; S Farholt; J Henrichsen; A Hornsleth; M Kilian; J S Jensen
Journal:  Clin Infect Dis       Date:  1996-11       Impact factor: 9.079

6.  Epidemiology and clinical manifestations of children with macrolide-resistant Mycoplasma pneumoniae pneumonia in Taiwan.

Authors:  Ping-Sheng Wu; Luan-Yin Chang; Hsiao-Chuan Lin; Hsin Chi; Yu-Chia Hsieh; Yi-Chuan Huang; Ching-Chuan Liu; Yhu-Chering Huang; Li-Min Huang
Journal:  Pediatr Pulmonol       Date:  2012-11-20

7.  An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.

Authors:  Yun-Fong Ngeow; Subharee Suwanjutha; Teerachai Chantarojanasriri; Fu Wang; Mediadora Saniel; Marissa Alejandria; Po-Ren Hsueh; Lee Ping-Ing; Seung-Chul Park; Jang-Wook Sohn; Ahmad M Aziah; Youning Liu; Wing-Hong Seto; Cecilia C L Ngan; Mangunnegoro Hadiarto; Alsagaff Hood; Yuet-Meng Cheong
Journal:  Int J Infect Dis       Date:  2004-11-25       Impact factor: 3.623

8.  Mycoplasma pneumoniae infection induces reactive oxygen species and DNA damage in A549 human lung carcinoma cells.

Authors:  Gongping Sun; Xuefeng Xu; Yingshuo Wang; Xiaoyun Shen; Zhimin Chen; Jun Yang
Journal:  Infect Immun       Date:  2008-07-28       Impact factor: 3.441

9.  Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012.

Authors:  Fei Zhao; Gang Liu; Jiang Wu; Bin Cao; Xiaoxia Tao; Lihua He; Fanliang Meng; Liang Zhu; Min Lv; Yudong Yin; Jianzhong Zhang
Journal:  Antimicrob Agents Chemother       Date:  2012-12-21       Impact factor: 5.191

10.  An outbreak of Mycoplasma pneumoniae caused by a macrolide-resistant isolate in a nursery school in China.

Authors:  Yong Wang; Shaofu Qiu; Guang Yang; Lixue Song; Wenli Su; Yuanyong Xu; Leili Jia; Ligui Wang; Rongzhang Hao; Chuanfu Zhang; Jingmei Liu; Xiuping Fu; Jinrong He; Jingshan Zhang; Zhenjun Li; Hongbin Song
Journal:  Antimicrob Agents Chemother       Date:  2012-05-14       Impact factor: 5.191

View more
  3 in total

1.  Outbreak of macrolide-resistant mycoplasma pneumoniae in a primary school in Beijing, China in 2018.

Authors:  Wen-Zeng Zhang; Song-Jian Zhang; Quan-Yi Wang; Yin-Dong Li; Hong-Bo Jing; Guang-Yi Hu; Dan Wu
Journal:  BMC Infect Dis       Date:  2019-10-22       Impact factor: 3.090

2.  Characteristics and Outcome of Severe Mycoplasma pneumoniae Pneumonia Admitted to PICU in Shanghai: A Retrospective Cohort Study.

Authors:  Yiping Zhou; Yijun Shan; Yun Cui; Jingyi Shi; Fei Wang; Huijie Miao; Chunxia Wang; Yucai Zhang
Journal:  Crit Care Explor       Date:  2021-03-23

3.  Dynamic change of Mycoplasma pneumoniae pneumonia in hospitalized children in a general hospital: a 3-year retrospective analysis.

Authors:  Yan Xing; Dan Wang; Kai Sheng; Xiumei Xiao; Hongling Wei; Ling Liu; Wei Zhou; Xiaomei Tong
Journal:  Transl Pediatr       Date:  2020-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.